Extracellular Vesicles in Alzheimer's Disease: from Pathology to Therapeutic Approaches

Overview

Journal Neural Regen Res

Date 2022 Jul 8

PMID 35799503

Authors

Marta Garcia-Contreras

Avnesh S Thakor

Affiliations

Soon will be listed here.

Abstract

Alzheimer's disease is a progressive and fatal neurodegenerative disorder that starts many years before the onset of cognitive symptoms. Identifying novel biomarkers for Alzheimer's disease has the potential for patient risk stratification, early diagnosis, and disease monitoring in response to therapy. A novel class of biomarkers is extracellular vesicles given their sensitivity and specificity to specific diseases. In addition, extracellular vesicles can be used as novel biological therapeutics given their ability to efficiently and functionally deliver therapeutic cargo. This is critical given the huge unmet need for novel treatment strategies for Alzheimer's disease. This review summarizes and discusses the most recent findings in this field.

Citing Articles

Mapping the current trends and hotspots of extracellular vesicles in Alzheimer's disease: a bibliometric analysis.

Xing X, Liu H, Zhang M, Li Y Front Aging Neurosci. 2025; 16:1485750.

PMID: 39759397 PMC: 11697149. DOI: 10.3389/fnagi.2024.1485750.

Shared and distinct changes in the molecular cargo of extracellular vesicles in different neurodegenerative diseases.

Wiersema A, Rennenberg A, Smith G, Varderidou-Minasian S, Pasterkamp R Cell Mol Life Sci. 2024; 81(1):479.

PMID: 39627617 PMC: 11615177. DOI: 10.1007/s00018-024-05522-7.

The Quest for Eternal Youth: Hallmarks of Aging and Rejuvenating Therapeutic Strategies.

Nunkoo V, Cristian A, Jurcau A, Diaconu R, Jurcau M Biomedicines. 2024; 12(11).

PMID: 39595108 PMC: 11591597. DOI: 10.3390/biomedicines12112540.

Arc mediates intercellular tau transmission via extracellular vesicles.

Tyagi M, Chadha R, de Hoog E, Sullivan K, Walker A, Northrop A bioRxiv. 2024; .

PMID: 39484489 PMC: 11526995. DOI: 10.1101/2024.10.22.619703.

Proteomic Profile of Circulating Extracellular Vesicles in the Brain after Δ9-Tetrahydrocannabinol Inhalation.

Lallai V, Lam T, Garcia-Milian R, Chen Y, Fowler J, Manca L Biomolecules. 2024; 14(9).

PMID: 39334909 PMC: 11430348. DOI: 10.3390/biom14091143.

References

de Godoy M, Saraiva L, de Carvalho L, Vasconcelos-Dos-Santos A, Beiral H, Ramos A . Mesenchymal stem cells and cell-derived extracellular vesicles protect hippocampal neurons from oxidative stress and synapse damage induced by amyloid-β oligomers. J Biol Chem. 2017; 293(6):1957-1975. PMC: 5808759. DOI: 10.1074/jbc.M117.807180. View

Alvarez-Erviti L, Seow Y, Yin H, Betts C, Lakhal S, Wood M . Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol. 2011; 29(4):341-5. DOI: 10.1038/nbt.1807. View

Daaboul G, Gagni P, Benussi L, Bettotti P, Ciani M, Cretich M . Digital Detection of Exosomes by Interferometric Imaging. Sci Rep. 2016; 6:37246. PMC: 5112555. DOI: 10.1038/srep37246. View

Goetzl E, Boxer A, Schwartz J, Abner E, Petersen R, Miller B . Altered lysosomal proteins in neural-derived plasma exosomes in preclinical Alzheimer disease. Neurology. 2015; 85(1):40-7. PMC: 4501943. DOI: 10.1212/WNL.0000000000001702. View

Kowal J, Arras G, Colombo M, Jouve M, Morath J, Primdal-Bengtson B . Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes. Proc Natl Acad Sci U S A. 2016; 113(8):E968-77. PMC: 4776515. DOI: 10.1073/pnas.1521230113. View

Muraoka S, Jedrychowski M, Yanamandra K, Ikezu S, Gygi S, Ikezu T . Proteomic Profiling of Extracellular Vesicles Derived from Cerebrospinal Fluid of Alzheimer's Disease Patients: A Pilot Study. Cells. 2020; 9(9). PMC: 7565882. DOI: 10.3390/cells9091959. View

Yang T, Liu C, Gao S, Zhang Y, Wang P . The Serum Exosome Derived MicroRNA-135a, -193b, and -384 Were Potential Alzheimer's Disease Biomarkers. Biomed Environ Sci. 2018; 31(2):87-96. DOI: 10.3967/bes2018.011. View

Lane R, Korbie D, Trau M, Hill M . Optimizing Size Exclusion Chromatography for Extracellular Vesicle Enrichment and Proteomic Analysis from Clinically Relevant Samples. Proteomics. 2019; 19(8):e1800156. DOI: 10.1002/pmic.201800156. View

Goetzl E, Abner E, Jicha G, Kapogiannis D, Schwartz J . Declining levels of functionally specialized synaptic proteins in plasma neuronal exosomes with progression of Alzheimer's disease. FASEB J. 2017; 32(2):888-893. PMC: 5888398. DOI: 10.1096/fj.201700731R. View

10.

Dinkins M, Dasgupta S, Wang G, Zhu G, Bieberich E . Exosome reduction in vivo is associated with lower amyloid plaque load in the 5XFAD mouse model of Alzheimer's disease. Neurobiol Aging. 2014; 35(8):1792-800. PMC: 4035236. DOI: 10.1016/j.neurobiolaging.2014.02.012. View

11.

Wang G, Dinkins M, He Q, Zhu G, Poirier C, Campbell A . Astrocytes secrete exosomes enriched with proapoptotic ceramide and prostate apoptosis response 4 (PAR-4): potential mechanism of apoptosis induction in Alzheimer disease (AD). J Biol Chem. 2012; 287(25):21384-95. PMC: 3375560. DOI: 10.1074/jbc.M112.340513. View

12.

Muraoka S, Jedrychowski M, Iwahara N, Abdullah M, Onos K, Keezer K . Enrichment of Neurodegenerative Microglia Signature in Brain-Derived Extracellular Vesicles Isolated from Alzheimer's Disease Mouse Models. J Proteome Res. 2021; 20(3):1733-1743. PMC: 7944570. DOI: 10.1021/acs.jproteome.0c00934. View

13.

Davies R, Kim J, Jang S, Choi E, Gho Y, Park J . Microfluidic filtration system to isolate extracellular vesicles from blood. Lab Chip. 2012; 12(24):5202-10. DOI: 10.1039/c2lc41006k. View

14.

Lugli G, Cohen A, Bennett D, Shah R, Fields C, Hernandez A . Plasma Exosomal miRNAs in Persons with and without Alzheimer Disease: Altered Expression and Prospects for Biomarkers. PLoS One. 2015; 10(10):e0139233. PMC: 4591334. DOI: 10.1371/journal.pone.0139233. View

15.

Ruan Z, Pathak D, Kalavai S, Yoshii-Kitahara A, Muraoka S, Bhatt N . Alzheimer's disease brain-derived extracellular vesicles spread tau pathology in interneurons. Brain. 2020; 144(1):288-309. PMC: 7880668. DOI: 10.1093/brain/awaa376. View

16.

Scarth M, Rissanen I, Scholten R, Geerlings M . Biomarkers of Alzheimer's Disease and Cerebrovascular Lesions and Clinical Progression in Patients with Subjective Cognitive Decline: A Systematic Review. J Alzheimers Dis. 2021; 83(3):1089-1111. DOI: 10.3233/JAD-210218. View

17.

Sinha M, Ansell-Schultz A, Civitelli L, Hildesjo C, Larsson M, Lannfelt L . Alzheimer's disease pathology propagation by exosomes containing toxic amyloid-beta oligomers. Acta Neuropathol. 2018; 136(1):41-56. PMC: 6015111. DOI: 10.1007/s00401-018-1868-1. View

18.

Bano R, Ahmad F, Mohsin M . A perspective on the isolation and characterization of extracellular vesicles from different biofluids. RSC Adv. 2022; 11(32):19598-19615. PMC: 9033677. DOI: 10.1039/d1ra01576a. View

19.

Su H, Rustam Y, Masters C, Makalic E, McLean C, Hill A . Characterization of brain-derived extracellular vesicle lipids in Alzheimer's disease. J Extracell Vesicles. 2021; 10(7):e12089. PMC: 8111496. DOI: 10.1002/jev2.12089. View

20.

Goetzl E, Mustapic M, Kapogiannis D, Eitan E, Lobach I, Goetzl L . Cargo proteins of plasma astrocyte-derived exosomes in Alzheimer's disease. FASEB J. 2016; 30(11):3853-3859. PMC: 5067254. DOI: 10.1096/fj.201600756R. View